The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose: 

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

Rep. Rulli Introduces PEAT Act to Save DTE Compounding and Access

Congressman Michael Rulli (OH-06) introduced the Protecting Equal Access to Thyroid (PEAT) Act of 2026 (HR 8630), legislation to protect patient access to desiccated thyroid extract (DTE), a treatment Americans have safely relied on since the late 1800s. Nearly 2 million Americans living with hypothyroidism, Hashimoto’s disease, and related conditions depend on DTE. Without this bill, FDA’s recent decision to classify this treatment as a biologic would require manufacturers to obtain a Biologics License Agreement by August 2026. The reclassification would also eliminate the ability of pharmacists to compound this treatment. The PEAT Act clarifies that a drug should not be classified as a biologic solely because it contains a clinically inactive protein, aligning federal policy with the FDA’s own guidance on inactive ingredients and preventing unnecessary regulatory overreach. 

The legislation is supported by the National Community Pharmacists Association, the Professional Compounding Centers of America, and the Alliance for Pharmacy Compounding. 

[HR 8630. Congress.gov; Rulli Bill Will Keep Natural Thyroid on Shelves Ahead of August Deadline. Office of Rep. Michael Rulli 13 May 2026.]